Xconomy

NOVEMBER 8, 2019

Those drugs have now become the center of a patent dispute between the Foster City, CA, drug maker and the federal government. This week, the government filed a patent infringement suit in federal court against Gilead (NASDAQ: GILD ). A key part of that plan are HIV prevention drug made by Gilead Sciences.

Patents 65

Patents Research San Diego Blogging 65

Xconomy

SEPTEMBER 14, 2018

The long running patent feud over CRISPR-Cs9 gene editing appears to be over, just as U.S. This week, a federal appeals court upheld a previous ruling handing a CRISPR-Cas9 patent to the Broad Institute of MIT and Harvard. biotech companies gear up for the first human tests of the landmark technology. Berkeley could appeal to the U.S.

Patents 52

Patents Technology San Diego Company 52

Xconomy

JUNE 25, 2019

Pharmaceutical giant AbbVie this morning agreed to acquire Allergan in a $63 billion deal meant to provide the pharmaceutical giant with enough revenue to brace for the loss of patent protection for the world’s top-selling drug. AbbVie (NYSE: ABBV ) will pay $188.24

Patents 82

Patents San Diego Blogging 82

Xconomy

JUNE 3, 2016

Merck also saw some expected fruits of its 2014 big-ticket acquisition of Cubist Pharmaceuticals wither away this week, as the Supreme Court wouldn’t reverse a decision that shaved years off the patent life of the top-selling antibiotic daptomyicin (Cubicin). billion acquisition of San Diego’s Auspex Pharmaceuticals last year.

San Diego 62

San Diego Patents Acquisition News 62

Xconomy

SEPTEMBER 21, 2017

This week our guest is Nathan Myhrvold , the former Microsoft chief technology officer who, since 2000, has headed Intellectual Ventures, a Bellevue, WA-based firm that buys, develops, and licenses technology patents and other intellectual property. He has so many interests and projects that we could easily have spent the entire.

Chief Technology Officer 85

Chief Technology Officer Patents Entrepreneur Technology 85

Xconomy

MARCH 2, 2018

Now, the Arkansas-based giant says it has filed two patents on technology that can digitize the current inspection process for perishable goods. Food spoilage can cost big retailers like Walmart billions in losses.

Artificial Inteligence 81

Artificial Inteligence Patents Ideas Technology 81

Xconomy

JANUARY 25, 2019

After guiding the CRISPR-Cas9 genome-editing startup from scientific breakthrough toward the development of a potential cutting-edge medicine, slogging victoriously through a legendary patent fight , and reaching the cusp of an historic clinical trial , the well-traveled Bosley is cutting out, the company said Tuesday.

Guide 63

Guide Patents Startup Develop 63

Xconomy

MARCH 22, 2018

Bose’s Steve Romine says that’s still an important focus for the Framingham, MA-based company, which has been awarded hundreds of patents for advances in technologies such as noise-canceling headphones. But in the past few years, Bose has also started to look outside its walls for other sources of innovation.

Venture Capital 70

Venture Capital Patents Research Invest 70

Xconomy

MARCH 17, 2017

Hosts Tom Haugh and Kathy Dervin bantered with me about the challenges of building companies outside the coastal tech hubs, how long it will really take to make fully autonomous vehicles a reality, whether our patent system causes more trouble than it’s worth, and much more. (I I also made some biased predictions about.

Patents 52

Patents Venture Capital Startup Capital 52

Xconomy

AUGUST 19, 2016

All those years of hard work to reach the promised land, then just as a drug owner is ready to spike it home and take a victory lap, the FDA’s hands rise over the net… OK, it’s not a perfect analogy, but it’s better than comparing the patent fight over the gene editing system CRISPR-Cas9 to table tennis. (Be

Technical Review 40

Technical Review Patents .Net Study 40

Xconomy

NOVEMBER 11, 2016

—Oral arguments in the landmark patent fight over ownership of the gene editing technology CRISPR-Cas9 were set for Dec. Patent and Trademark Office. —Despite the patent fight, CRISPR work continues apace. —Despite the patent fight, CRISPR work continues apace. CRISPR DEVELOPMENTS. 6 at the U.S.

Patents 87

Patents Study Pricing Research 87

Xconomy

FEBRUARY 10, 2017

All this, plus heart-stopping patent fights, drug-price intrigue, a regenerative chat with inventor Dean Kamen, and more. Patient advocates have scored big wins with recent approvals of rare disease treatments, but they’re not as happy with insurers’ coverage decisions or with Trump’s promises of massive FDA deregulation.

Patents 40

Patents Pricing San Diego Blogging 40

Xconomy

DECEMBER 9, 2016

—arguments from both sides of the epic CRISPR patent fight. President-elect Donald Trump re-stirred the drug-pricing pot with comments in Time Magazine and a reported FDA commissioner candidate who doesn’t seem to think much of the regulatory process. And a trio of judges met to hear brief—can we say edited?—arguments

News 40

News Patents Conference Pricing 40

Xconomy

AUGUST 2, 2019

Blockbuster drugs such as Viagra and Lipitor, which came via acquisitions, are currently sold by Upjohn, Pfizer’s off-patent drug division. But as the company maps its future, CEO Albert Bourla is breaking some of that legacy apart.

Patents 18

Patents Acquisition Product Develop 18

Xconomy

MAY 30, 2016

X: I read an article from 1998 that you were quoted in—it sounded like Stanford’s Niels Reimers helped MIT reorganize its patenting and licensing office in 1986 to make it more like Stanford’s model. It basically helped invent the ultra-filtration field. Then it got acquired by Millipore. LN: Right, he came on a sabbatical year.

Startup 67

Startup Compton Research Technology 67

Xconomy

SEPTEMBER 6, 2019

Being first to market with a new type of drug brings advantages. The first mover sets the bar for what physicians, payers, and patients can expect of that medicine and how much it costs. It grabs market share that followers have to steal away. But the first mover isn’t infallible if someone else has something better. is counting on.

Pricing 84

Pricing Class Study Marketing 84

Xconomy

JUNE 29, 2016

But as I explain in a longer blog post , what is copied is a common motif in song composition, effectively a design tool. For those who follow IP law, this is the tension behind the “abstraction test” in copyright and the recent Supreme Court software patent decision in Alice Corp. There may be vocals, guitars, bass, drums, etc.

Tool 55

Tool Design IP Examples 55

Xconomy

FEBRUARY 15, 2019

No longer solely the provenance of hippie or outlaw types, the U.S. cannabis industry has become more sophisticated and tech-enabled as it has come out of the shadows over the past decade. Michigan voters pushed the state to joined the ranks of nine others last fall in approving adult use of recreational marijuana.

IP 91

IP Research Product Develop 91

Xconomy

JULY 26, 2019

What will the legacy be of Jeff Leiden, the longtime CEO of Vertex Pharmaceuticals? Vertex surprised Wall Street this week by announcing Leiden’s seven-year run will end next spring. In some ways, his legacy is already written. He steered Vertex through a crisis when its hepatitis C business was squashed by competition.

Pricing 77

Pricing Competition San Diego Patents 77

Xconomy

MARCH 8, 2019

In early 2017, Scott Gottlieb was considered the most moderate of the potential candidates to head the Food and Drug Administration, which is the most powerful regulator of medical products in the world. It wasn’t a high bar to clear.

Report 77

Report Product San Diego Pricing 77

Xconomy

JUNE 28, 2019

It was a busy week. If we had to choose a theme, it was all about getting together. Two huge drug companies, AbbVie and Allergan, said they’d be better as one. Two more huge drug companies, Celgene and Bristol-Myers Squibb, learned they would have to leave a big product behind if they want to merge.

Product 65

Product Company Companies San Diego 65

Xconomy

AUGUST 16, 2019

We learned last week that the FDA was investigating Novartis for manipulating animal data related to its $2 million-a-dose gene therapy Zolgensma. The activity took place at AveXis, the firm Novartis bought for $8.7 billion in 2018, and Novartis reportedly knew but failed to report it to the FDA before the agency approved Zolgensma in May.

Report 63

Report Activity San Diego Study 63

Xconomy

MARCH 2, 2018

These days, it’s not just Snow White’s stepmother who has a mirror that talks back. Thanks to augmented reality, Internet of Things, and data analytics technologies, more of us might be confronted with so-called “smart mirrors” the next time we try on clothes or accessories in a store.

High Tech 69

High Tech Artificial Inteligence Technology San Diego 69

Xconomy

JANUARY 19, 2018

The most overblown health story of the week was President Trump’s health exam. America learned Trump is in perfect health and has “ great genes.” ” He takes Propecia. He doesn’t have heart problems, had a perfect cognitive test score, and is one pound shy of obese.

Social Media 57

Social Media News Media San Diego 57

Xconomy

OCTOBER 27, 2017

The White House and the FDA turned the spotlight on the nation’s opioid crisis. Blockbuster drugs from Alexion and Tesaro gained expanded approvals, but bad earnings news from Celgene and Biogen brought stocks down. Academics in the U.S. and China made progress with the gene editing technology CRISPR.

News 57

News Research Technology San Diego 57

SoCal Delicious

MAY 6, 2012

Charlie Capen is co-founder of HowToBeADad.com , an entertainment site and dad blog for “parents, soon-to-be parents and people who have no desire to procreate, whatsoever.” Heather McPhaul is the founder of AgingGal.com , a funny little blog about aging and other inconveniences. She just spoke at TED EX in San Diego.

Los Angeles 78

Los Angeles Entrepreneur Angel Fractional CTO 78